Valor pronóstico del inmunofenotipo en la respuesta temprana de la leucemia aguda linfoblástica pre-B en niños

Correa-González, Lourdes Cecilia; Mandeville, Peter B; Manrique-Dueñas, Javier; Alejo-González, Francisco; Salazar-Martínez, Abel; Pérez-Ramírez, Oscar de Jesús; Hernández-Sierra, Juan Francisco.
Gac. méd. Méx ; 141(6): 477-482, nov.-dic. 2005. tab
Artículo en Español | LILACS | ID: lil-632135

Documentos relacionados

  1. CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
  2. Efficacy and Safety of Blinatumomab for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Systemic Review and Meta-Analysis.
  3. Bispecific T-cell engagers in childhood B-acute lymphoblastic leukemia.
  4. Biochemical and Hematologic Profiles in B-Cell Acute Lymphoblastic Leukemia Children.
  5. A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.
  6. [Prognostic value of pre-B immunophenotype in early treatment response among acute pediatric lymphoblast leukemia patients].
  7. Cuplike nuclei in B-cell acute lymphoblastic leukemia with DUX4 rearrangement.
  8. The prognostic impact of IKZF1 deletions and UKALL genetic classifiers in paediatric B-cell precursor acute lymphoblastic leukaemia treated according to NOPHO 2008 protocols.
  9. Treatment of Recurrent Refractory Pediatric Pre-B Acute Lymphoblastic Leukemia Using Inotuzumab Ozogamicin Monotherapy Resulting in CD22 Antigen Expression Loss as a Mechanism of Therapy Resistance.
  10. A Review of Clinical Outcomes of CAR T-Cell Therapies for B-Acute Lymphoblastic Leukemia.